VKTX icon

Viking Therapeutics
VKTX

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$95
176% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Canaccord Genuity
Canaccord Genuity
Edward Nash
50% 1-yr VKTX win rate
12 Nov ‘25 2 months ago
JP Morgan
JP Morgan
Hardik Parikh
100% 1-yr VKTX win rate
24 Oct ‘25 2 months ago
Morgan Stanley
Morgan Stanley
Michael Ulz
100% 1-yr VKTX win rate
23 Oct ‘25 2 months ago